Baxter Recalls Vancomycin Injection Due to CGMP Deviations
Baxter Healthcare is voluntarily recalling specific lots of Vancomycin Injection due to Current Good Manufacturing Practice (CGMP) deviations.
What this means for you
Illness, injury, or structural failure has been reported. Stop using the product immediately and contact the manufacturer for a refund or repair.
Our severity reasoning: The source text explicitly states the FDA classification is Class II. According to the severity rubric, an FDA Class II recall corresponds to a score of 4 (Severe), particularly given the nature of the product and the CGMP deviations involved.
Plain-English summary
Baxter Healthcare Corporation is voluntarily recalling Vancomycin Injection, USP, in 0.9% Sodium Chloride, 1g per 200 mL (5 mg/mL) in GALAXY Single-Dose Container. The recall affects Lot # NC193894 with an expiration date of 04/25/2027. The product is identified by NDC 0338-3583-01.
The recall was initiated by the firm on August 6, 2026, due to Current Good Manufacturing Practice (CGMP) deviations. The FDA has classified this recall as Class II, which indicates a situation where use of, or exposure to, the violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote.
The affected product was distributed nationwide in the United States, as well as in Puerto Rico and Chile. Healthcare providers and patients should discontinue use of the affected lot and contact their pharmacist or Baxter Healthcare for further instructions.
The recalled product
- Product
- VANCOMYCIN HYDROCHLORIDE (VANCOMYCIN HYDROCHLORIDE)
- Brand
- VANCOMYCIN HYDROCHLORIDE
- Manufacturer
- Baxter Healthcare Corporation
- Category
- Drug — Antibiotic Injection
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (2)
- Lot # NC193894
- Exp Date: 04/25/2027.
Distribution
Related recalls
Same brand · VANCOMYCIN HYDROCHLORIDE
- HighBaxter Recalls Vancomycin Injection Due to Manufacturing Deviations
FDA (Drugs) · 2026-09-09
- SevereVancomycin Hydrochloride Oral Solution Recalled Nationwide for Superpotency Due to Overfilling
FDA (Drugs) · 2024-04-24
- CriticalVancomycin Hydrochloride Injection Recalled for Glass Particulate Matter
FDA (Drugs) · 2023-02-01
- ModerateAuroMedics Recalls Vancomycin Hydrochloride Vials Due to Discoloration
FDA (Drugs) · 2019-12-18
- CriticalPfizer Recalls Vancomycin Hydrochloride Vials Due to Glass Particulate Matter
FDA (Drugs) · 2017-12-27
Same manufacturer · Baxter Healthcare Corporation
See all →- SevereBaxter Recalls Daptomycin Injection Due to Manufacturing Deviations
FDA (Drugs) · 2026-09-09
- ModerateBaxter Recalls Pantoprazole Sodium Infusion Bags Due to Manufacturing Deviations
FDA (Drugs) · 2026-09-09
- HighBaxter Recalls Clindamycin Injection Due to Manufacturing Deviations
FDA (Drugs) · 2026-09-09
- SevereBaxter Recalls Vasopressin Injection Due to Manufacturing Deviations
FDA (Drugs) · 2026-09-09
- HighBaxter Novum IQ Syringe Pump Recalled for Software Infusion Issue
FDA (Devices) · 2026-09-09
Same hazard · cgmp deviation
See all →- ModerateLexia LLC Recalls Broadway Joe's Pain Cream Due to CGMP Deviations
FDA (Drugs) · 2026-09-09
- SevereBaxter Recalls Daptomycin Injection Due to Manufacturing Deviations
FDA (Drugs) · 2026-09-09
- HighBaxter Recalls CARDENE IV Nicardipine Injection Due to Manufacturing Deviations
FDA (Drugs) · 2026-09-09
- SevereBaxter Recalls Clindamycin Injection Due to Manufacturing Deviations
FDA (Drugs) · 2026-09-09